HYFT
MindWalk Holdings Corp.
Healthcare — Biotechnology
MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
Price History
Fundamentals
| Market Cap | $75.67M |
| P/E Ratio (TTM) | - |
| Forward P/E | - |
| EPS (TTM) | $-0.10 |
| Dividend Yield | - |
| Profit Margin | -43.60% |
| Revenue Growth | 52.40% |
| ROE | -58.82% |
| Debt/Equity | 23.72 |
| Recommendation | None |
| Analyst Target | $4.33 |
| Analysts | 3 |
| Next Earnings | Sep 14, 2026 AMC |
| Indexes | - |
Technical Indicators
| RSI (14) | 50.8 |
| Beta | 0.82 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $3.25 |
| 52-Week Low | $0.99 |
| 50-Day Avg | $1.47 |
| 200-Day Avg | $1.60 |
| Avg Volume | 346.0K |
| Volume | 163.9K |
Performance Analysis
NEUTRALHYFT presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 13:14 UTC
Back to Screener Export Report